pfizer

The FDA advisory committee voted to recommend emergency use authorization for the Johnson & Johnson COVID-19 vaccine.

Pfizer announced Thursday the company is launching a new study of its COVID-19 vaccine. They’re going back to 144 phase 1 clinical trial participants with a third dose – a booster shot. It comes a day after Moderna also announced a third-shot study. “These companies are doing their due diligence to stay on track of this virus as it’s mutating…

Pfizer and Moderna announce plans to test a third COVID-19 shot as a booster against the new variants of the virus.

The FDA could approve a new one-shot COVID vaccine by Friday, as Congress decides on COVID relief bill details. The Johnson & Johnson one-shot vaccine is over 20 percent less effective than Pfizer and Moderna’s, but still far better than a flu shot.

A large real-world test of Pfizer’s COVID-19 vaccine confirms that it’s very effective at preventing serious illness or death, even after one dose

COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month.

The grim milestone means the U.S. continues to lead the world in overall cases and deaths.

It takes Pfizer 110 days to produce a batch of its COVID-19 vaccine. The company says it expects to soon shorten that time to 60 days.

Pfizer announced on Tuesday that it is months ahead of schedule to deliver 200 million doses of its coronavirus vaccine to the U.S. The shipment should be available to Americans starting in May.

A new study suggests that Pfizer/BioNtech’s coronavirus vaccine appears to work against new variants that have begun circulating in the U.S. The study has not been peer-reviewed or published in a medical journal.

Britain’s main doctors’ organization says it is concerned about the U.K.’s decision to give people a second dose of coronavirus vaccine up to 12 weeks after the first, rather than the shorter gap recommended by manufacturers and the World Health Organization

As states and medical centers roll out COVID-19 vaccines, many are highlighting recipients from a variety of racial and ethnic backgrounds to build trust. This is in part due to vaccine hesitancy, especially in Black communities where a history of medical testing without consent and inadequate access to health care has built distrust. A recent study by the Kaiser Family...

Coronavirus vaccinations are well underway in New York, New Jersey and Connecticut. The three states have received about 1 million doses thus far and expect hundreds of thousands more in allocations before the month is out. While they have slightly different rollout plans as far as timing, all three states are subscribing to the priority population guidance issued by the…

Health experts are debating what to tell study volunteers who got a placebo shot instead of a COVID-19 vaccine.

The U.S. government is close to a deal with Pfizer to acquire tens of millions of additional vaccine doses in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies

President-elect Joe Biden received his first dose of the coronavirus vaccine on live television as part of a growing effort to convince the American public the inoculations are safe

President-elect Joe Biden received the first dose of the Pfizer vaccine on Monday. “This is just the beginning,” he said. “I hope people listen to all the experts… talking about the need to wear masks.”

This is probably not what Dippin’ Dots had in mind when describing itself as the “Ice Cream of the Future.”

Two COVID-19 vaccines have now been approved for emergency use by the U.S. Food and Drug Administration as the nation continues to see record numbers of coronavirus cases. In the midst of all the news from Pfizer and Moderna, though, another company has announced it made progress in its own vaccine trials. Johnson & Johnson took a big step...

The Army general in charge of getting COVID-19 vaccines across the United States is apologizing for what he calls “miscommunication” with states over the number of doses to be delivered in the early stages of distribution